The Canadian province of Ontario has recorded its first blood clotting event following vaccination with the AstraZeneca coronavirus vaccine, the province’s Chief Medical Officer David Williams said on Friday.
“We have confirmed the first case of the rare blood clotting condition known as vaccine-induced immune thrombotic thrombocytopenia (VITT) in Ontario. The patient is a male in his 60s who had received his first dose of the AstraZeneca/COVISHIELD vaccine. The patient has received treatment and is recovering at home,” Williams said in a statement.
Ontario would not release further information to protect the identity of the individual in question, the statement said.
The province’s first episode marks the fourth blood clotting event in Canada, with 1.1 million doses of the AstraZeneca vaccine having been administered.
